Utility of baseline, interim and end-of-treatment 18 F-FDG PET/CT in extranodal natural killer/T-cell lymphoma patients treated with L-asparaginase/pegaspargase

Yu Chang,Xiaorui Fu,Zhenchang Sun,Xinli Xie,Ruihua Wang,Zhaoming Li,Xudong Zhang,Guangyao Sheng,Mingzhi Zhang

Utility of baseline, interim and end-of-treatment 18 F-FDG PET/CT in extranodal natural killer/T-cell lymphoma patients treated with L-asparaginase/pegaspargase

2017

Yu Chang
Xiaorui Fu
Zhenchang Sun
Xinli Xie
Ruihua Wang
Zhaoming Li
Xudong Zhang
Guangyao Sheng
Mingzhi Zhang

Utility of baseline, interim and end-of-treatment 18 F-FDG PET/CT in extranodal natural killer/T-cell lymphoma patients treated with L-asparaginase/pegaspargase

Keywords:

Lymphoma
Interim
Natural killer T cell
Cancer research
Asparaginase
Pegaspargase
Nuclear medicine
PET-CT
Medicine
Multivariate analysis
Young adult
Retrospective cohort study
Stage (cooking)

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations